Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Reneo Pharmaceuticals Inc (RPHM)

Reneo Pharmaceuticals Inc (RPHM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Reneo Pharmaceuticals Inc 18575 Jamboree Road Suite 275-S Irvine CA 92612 USA

https://reneopharma.com P: 858-283-0280

Description:

Reneo Pharmaceuticals Inc.is a clinical stage pharmaceutical company. It is focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases. Reneo Pharmaceuticals Inc.is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 60,492
Enterprise Value, $K 32,862
Shares Outstanding, K 33,421
Annual Sales, $ 0 K
Annual Net Income, $ -77,390 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -23,550 K
EBIT, $ -83,050 K
EBITDA, $ -87,010 K
60-Month Beta 0.22
% of Insider Shareholders 17.90%
% of Institutional Shareholders 90.98%
Float, K 27,439
% Float 82.10%
Short Volume Ratio 0.42

Growth:

1-Year Return -77.32%
3-Year Return -76.74%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 05/07/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -2.52
EPS Growth vs. Prev Qtr 64.29%
EPS Growth vs. Prev Year 58.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RPHM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -67.76%
Return-on-Assets % -60.10%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.77
Book Value/Share 2.66
Interest Coverage -1.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar